Dapagliflozin as add-on therapy in Asian patients with type 2 diabetes inadequately controlled on insulin with or without oral antihyperglycemic drugs: A randomized controlled trial

2018 ◽  
Vol 10 (7) ◽  
pp. 589-599 ◽  
Author(s):  
Wenying Yang ◽  
Jianhua Ma ◽  
Yiming Li ◽  
Yanbing Li ◽  
Zhiguang Zhou ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Randomized Controlled ◽  
Asian Patients ◽  
Oral Antihyperglycemic Drugs

Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trial

2016 ◽  
Vol 8 (6) ◽  
pp. 796-808 ◽  
Author(s):  
Wenying Yang ◽  
Ping Han ◽  
Kyung-Wan Min ◽  
Bei Wang ◽  
Traci Mansfield ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Randomized Controlled ◽  
Asian Patients

1126-P: Randomized Controlled Trial of Ipragliflozin or Sitagliptin Combined with Metformin in Type 2 Diabetes: NISM Study

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 1126-P
Author(s):  
MASARU KITAZAWA ◽  
TAKASHI KATAGIRI ◽  
HIROMI SUZUKI ◽  
SATOSHI MATSUNAGA ◽  
MAYUKO H. YAMADA ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Controlled Trial ◽  
Randomized Controlled

scholarly journals Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial

2020 ◽  
Vol Volume 13 ◽  
pp. 423-431 ◽  
Author(s):  
Nuntakorn Thongtang ◽  
Jirasak Piyapromdee ◽  
Natthakan Tangkittikasem ◽  
Kittichai Samaithongcharoen ◽  
Nithiwat Srikanchanawat ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Randomized Controlled Trial ◽  
Primary Prevention ◽  
High Intensity ◽  
Low Dose ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Randomized Controlled
Sign in / Sign up

Export Citation Format

Share Document